The concept of the ‘Atopic March’ suggests that an impaired skin barrier (perhaps related to mutations in, for example, the filaggrin gene) renders individuals susceptible to atopic sensitization and thereafter vulnerable to atopic eczema and later to atopic rhinitis and atopic asthma 1. This evidence concerns the gene FLG and allergic rhinitis.